TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
暂无分享,去创建一个
C. Sotiriou | C. Desmedt | D. Larsimont | D. Rimm | M. Regan | M. Piccart-Gebhart | A. Di Leo | C. Oakman | C. Biagioni | E. Moretti | F. Galardi